nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxprenolol—ADRB1—dilated cardiomyopathy	0.528	0.543	CbGaD
Oxprenolol—ADRB2—dilated cardiomyopathy	0.444	0.457	CbGaD
Oxprenolol—SLC22A2—Organic cation transport—SLC22A5—dilated cardiomyopathy	0.00249	0.158	CbGpPWpGaD
Oxprenolol—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00169	0.107	CbGpPWpGaD
Oxprenolol—ADRB2—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.00113	0.072	CbGpPWpGaD
Oxprenolol—ADRB1—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.000937	0.0596	CbGpPWpGaD
Oxprenolol—Practolol—ADRB1—dilated cardiomyopathy	0.000801	0.0781	CrCbGaD
Oxprenolol—Metipranolol—ADRB1—dilated cardiomyopathy	0.000724	0.0707	CrCbGaD
Oxprenolol—Metipranolol—ADRB2—dilated cardiomyopathy	0.000609	0.0594	CrCbGaD
Oxprenolol—Esmolol—ADRB1—dilated cardiomyopathy	0.000575	0.0561	CrCbGaD
Oxprenolol—Betaxolol—ADRB1—dilated cardiomyopathy	0.000506	0.0494	CrCbGaD
Oxprenolol—Atenolol—ADRB1—dilated cardiomyopathy	0.000502	0.049	CrCbGaD
Oxprenolol—Penbutolol—ADRB1—dilated cardiomyopathy	0.000502	0.049	CrCbGaD
Oxprenolol—Bisoprolol—ADRB1—dilated cardiomyopathy	0.000489	0.0477	CrCbGaD
Oxprenolol—Esmolol—ADRB2—dilated cardiomyopathy	0.000484	0.0472	CrCbGaD
Oxprenolol—Acebutolol—ADRB1—dilated cardiomyopathy	0.000463	0.0452	CrCbGaD
Oxprenolol—Betaxolol—ADRB2—dilated cardiomyopathy	0.000426	0.0416	CrCbGaD
Oxprenolol—Penbutolol—ADRB2—dilated cardiomyopathy	0.000422	0.0412	CrCbGaD
Oxprenolol—Atenolol—ADRB2—dilated cardiomyopathy	0.000422	0.0412	CrCbGaD
Oxprenolol—Alprenolol—ADRB1—dilated cardiomyopathy	0.000421	0.041	CrCbGaD
Oxprenolol—Bisoprolol—ADRB2—dilated cardiomyopathy	0.000411	0.0401	CrCbGaD
Oxprenolol—ADRB2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.0004	0.0255	CbGpPWpGaD
Oxprenolol—Metoprolol—ADRB1—dilated cardiomyopathy	0.000391	0.0382	CrCbGaD
Oxprenolol—Acebutolol—ADRB2—dilated cardiomyopathy	0.00039	0.038	CrCbGaD
Oxprenolol—Pindolol—ADRB1—dilated cardiomyopathy	0.000362	0.0353	CrCbGaD
Oxprenolol—Alprenolol—ADRB2—dilated cardiomyopathy	0.000354	0.0345	CrCbGaD
Oxprenolol—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000338	0.0215	CbGpPWpGaD
Oxprenolol—ADRB2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.000336	0.0214	CbGpPWpGaD
Oxprenolol—ADRB1—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.000331	0.0211	CbGpPWpGaD
Oxprenolol—Metoprolol—ADRB2—dilated cardiomyopathy	0.000329	0.0321	CrCbGaD
Oxprenolol—ADRB2—Arf6 signaling events—AGTR1—dilated cardiomyopathy	0.000326	0.0207	CbGpPWpGaD
Oxprenolol—Pindolol—ADRB2—dilated cardiomyopathy	0.000304	0.0297	CrCbGaD
Oxprenolol—ADRB1—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000279	0.0177	CbGpPWpGaD
Oxprenolol—ADRB1—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000259	0.0165	CbGpPWpGaD
Oxprenolol—ADRB2—Arf6 trafficking events—AGTR1—dilated cardiomyopathy	0.000257	0.0164	CbGpPWpGaD
Oxprenolol—ADRB2—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000253	0.0161	CbGpPWpGaD
Oxprenolol—ADRB1—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000252	0.016	CbGpPWpGaD
Oxprenolol—ADRB2—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000246	0.0157	CbGpPWpGaD
Oxprenolol—ADRB2—Arf6 trafficking events—ITGB1—dilated cardiomyopathy	0.000236	0.015	CbGpPWpGaD
Oxprenolol—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000222	0.0141	CbGpPWpGaD
Oxprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000209	0.0133	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000204	0.013	CbGpPWpGaD
Oxprenolol—Propranolol—ADRB1—dilated cardiomyopathy	0.000197	0.0193	CrCbGaD
Oxprenolol—ADRB2—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.000183	0.0117	CbGpPWpGaD
Oxprenolol—ADRB1—Endothelin Pathways—RAF1—dilated cardiomyopathy	0.000171	0.0109	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000169	0.0107	CbGpPWpGaD
Oxprenolol—Propranolol—ADRB2—dilated cardiomyopathy	0.000166	0.0162	CrCbGaD
Oxprenolol—SLC22A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000154	0.00977	CbGpPWpGaD
Oxprenolol—ADRB2—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	0.000139	0.00883	CbGpPWpGaD
Oxprenolol—SLC22A2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000135	0.00859	CbGpPWpGaD
Oxprenolol—SLC22A2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000129	0.00823	CbGpPWpGaD
Oxprenolol—ADRB2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00012	0.00762	CbGpPWpGaD
Oxprenolol—ADRB1—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	0.000115	0.00731	CbGpPWpGaD
Oxprenolol—ADRB2—Arf6 signaling events—EGFR—dilated cardiomyopathy	0.000109	0.00695	CbGpPWpGaD
Oxprenolol—ADRB1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000101	0.00643	CbGpPWpGaD
Oxprenolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	9.92e-05	0.00632	CbGpPWpGaD
Oxprenolol—ADRB2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	9.89e-05	0.00629	CbGpPWpGaD
Oxprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	8.76e-05	0.00558	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	8.57e-05	0.00546	CbGpPWpGaD
Oxprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	8.15e-05	0.00519	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	8.02e-05	0.0051	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	7.97e-05	0.00507	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	7.8e-05	0.00497	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	7.8e-05	0.00497	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	7.72e-05	0.00491	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	7.51e-05	0.00478	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	7.51e-05	0.00478	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	7.35e-05	0.00468	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	7.35e-05	0.00468	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	7.25e-05	0.00462	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	6.98e-05	0.00444	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	6.83e-05	0.00435	CbGpPWpGaD
Oxprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	6.74e-05	0.00429	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	6.61e-05	0.00421	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	6.59e-05	0.0042	CbGpPWpGaD
Oxprenolol—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	6.47e-05	0.0477	CcSEcCtD
Oxprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	6.39e-05	0.00407	CbGpPWpGaD
Oxprenolol—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	6.27e-05	0.0461	CcSEcCtD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	5.77e-05	0.00368	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	5.72e-05	0.00364	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	5.72e-05	0.00364	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	5.65e-05	0.0036	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	5.59e-05	0.00356	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	5.59e-05	0.00356	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	5.48e-05	0.00349	CbGpPWpGaD
Oxprenolol—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	5.45e-05	0.0401	CcSEcCtD
Oxprenolol—Diplopia—Lisinopril—dilated cardiomyopathy	5.32e-05	0.0391	CcSEcCtD
Oxprenolol—ADRB1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	5.32e-05	0.00338	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ANKRD1—dilated cardiomyopathy	5.27e-05	0.00336	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	5.2e-05	0.00331	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	5.04e-05	0.00321	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—TAZ—dilated cardiomyopathy	4.96e-05	0.00315	CbGpPWpGaD
Oxprenolol—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	4.86e-05	0.0358	CcSEcCtD
Oxprenolol—Hypersensitivity—Spironolactone—dilated cardiomyopathy	4.72e-05	0.0347	CcSEcCtD
Oxprenolol—Pruritus—Spironolactone—dilated cardiomyopathy	4.53e-05	0.0333	CcSEcCtD
Oxprenolol—Bronchospasm—Lisinopril—dilated cardiomyopathy	4.52e-05	0.0333	CcSEcCtD
Oxprenolol—SLC22A2—Metabolism—SDHA—dilated cardiomyopathy	4.48e-05	0.00285	CbGpPWpGaD
Oxprenolol—Sweating increased—Lisinopril—dilated cardiomyopathy	4.48e-05	0.033	CcSEcCtD
Oxprenolol—ADRB1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	4.4e-05	0.0028	CbGpPWpGaD
Oxprenolol—Diarrhoea—Spironolactone—dilated cardiomyopathy	4.38e-05	0.0322	CcSEcCtD
Oxprenolol—ADRB2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	4.3e-05	0.00274	CbGpPWpGaD
Oxprenolol—Dizziness—Spironolactone—dilated cardiomyopathy	4.23e-05	0.0312	CcSEcCtD
Oxprenolol—ADRB1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	4.17e-05	0.00266	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	4.06e-05	0.00259	CbGpPWpGaD
Oxprenolol—Headache—Spironolactone—dilated cardiomyopathy	4.01e-05	0.0295	CcSEcCtD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	3.97e-05	0.00253	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	3.84e-05	0.00244	CbGpPWpGaD
Oxprenolol—Nausea—Spironolactone—dilated cardiomyopathy	3.8e-05	0.028	CcSEcCtD
Oxprenolol—Bradycardia—Lisinopril—dilated cardiomyopathy	3.75e-05	0.0276	CcSEcCtD
Oxprenolol—Thrombocytopenia—Furosemide—dilated cardiomyopathy	3.41e-05	0.0251	CcSEcCtD
Oxprenolol—Hyperhidrosis—Furosemide—dilated cardiomyopathy	3.37e-05	0.0248	CcSEcCtD
Oxprenolol—Hypotension—Furosemide—dilated cardiomyopathy	3.26e-05	0.024	CcSEcCtD
Oxprenolol—ADRB1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.23e-05	0.00206	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.23e-05	0.00206	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.16e-05	0.00201	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.16e-05	0.00201	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—AGT—dilated cardiomyopathy	3.09e-05	0.00197	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—AGT—dilated cardiomyopathy	3.03e-05	0.00193	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	3e-05	0.00191	CbGpPWpGaD
Oxprenolol—Fatigue—Furosemide—dilated cardiomyopathy	3e-05	0.0221	CcSEcCtD
Oxprenolol—SLC22A2—Neuronal System—RAF1—dilated cardiomyopathy	2.94e-05	0.00187	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	2.94e-05	0.00187	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	2.93e-05	0.00187	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	2.93e-05	0.00187	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	2.87e-05	0.00183	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	2.87e-05	0.00183	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	2.85e-05	0.00181	CbGpPWpGaD
Oxprenolol—Palpitations—Lisinopril—dilated cardiomyopathy	2.83e-05	0.0208	CcSEcCtD
Oxprenolol—Abdominal pain—Furosemide—dilated cardiomyopathy	2.75e-05	0.0203	CcSEcCtD
Oxprenolol—ADRB1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	2.73e-05	0.00174	CbGpPWpGaD
Oxprenolol—Arthralgia—Lisinopril—dilated cardiomyopathy	2.73e-05	0.0201	CcSEcCtD
Oxprenolol—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	2.71e-05	0.00173	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	2.67e-05	0.0017	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	2.58e-05	0.00165	CbGpPWpGaD
Oxprenolol—Hypersensitivity—Furosemide—dilated cardiomyopathy	2.57e-05	0.0189	CcSEcCtD
Oxprenolol—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	2.56e-05	0.0188	CcSEcCtD
Oxprenolol—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	2.55e-05	0.00162	CbGpPWpGaD
Oxprenolol—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	2.53e-05	0.0186	CcSEcCtD
Oxprenolol—Asthenia—Furosemide—dilated cardiomyopathy	2.5e-05	0.0184	CcSEcCtD
Oxprenolol—ADRB1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.48e-05	0.00158	CbGpPWpGaD
Oxprenolol—Pruritus—Furosemide—dilated cardiomyopathy	2.47e-05	0.0181	CcSEcCtD
Oxprenolol—Hypotension—Lisinopril—dilated cardiomyopathy	2.44e-05	0.018	CcSEcCtD
Oxprenolol—ADRB2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.43e-05	0.00155	CbGpPWpGaD
Oxprenolol—Diarrhoea—Furosemide—dilated cardiomyopathy	2.38e-05	0.0175	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	2.38e-05	0.0175	CcSEcCtD
Oxprenolol—Insomnia—Lisinopril—dilated cardiomyopathy	2.36e-05	0.0174	CcSEcCtD
Oxprenolol—ADRB1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.36e-05	0.0015	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	2.31e-05	0.00147	CbGpPWpGaD
Oxprenolol—Dizziness—Furosemide—dilated cardiomyopathy	2.3e-05	0.017	CcSEcCtD
Oxprenolol—Dyspepsia—Lisinopril—dilated cardiomyopathy	2.3e-05	0.0169	CcSEcCtD
Oxprenolol—ADRB1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.26e-05	0.00144	CbGpPWpGaD
Oxprenolol—Fatigue—Lisinopril—dilated cardiomyopathy	2.25e-05	0.0166	CcSEcCtD
Oxprenolol—ADRB2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.21e-05	0.00141	CbGpPWpGaD
Oxprenolol—Headache—Furosemide—dilated cardiomyopathy	2.18e-05	0.0161	CcSEcCtD
Oxprenolol—ADRB1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.14e-05	0.00136	CbGpPWpGaD
Oxprenolol—Nausea—Furosemide—dilated cardiomyopathy	2.07e-05	0.0152	CcSEcCtD
Oxprenolol—Abdominal pain—Lisinopril—dilated cardiomyopathy	2.07e-05	0.0152	CcSEcCtD
Oxprenolol—ADRB1—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.95e-05	0.00124	CbGpPWpGaD
Oxprenolol—Hypersensitivity—Lisinopril—dilated cardiomyopathy	1.93e-05	0.0142	CcSEcCtD
Oxprenolol—ADRB2—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.91e-05	0.00122	CbGpPWpGaD
Oxprenolol—Asthenia—Lisinopril—dilated cardiomyopathy	1.88e-05	0.0138	CcSEcCtD
Oxprenolol—Pruritus—Lisinopril—dilated cardiomyopathy	1.85e-05	0.0136	CcSEcCtD
Oxprenolol—ADRB1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.83e-05	0.00117	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.79e-05	0.00114	CbGpPWpGaD
Oxprenolol—Diarrhoea—Lisinopril—dilated cardiomyopathy	1.79e-05	0.0132	CcSEcCtD
Oxprenolol—ADRB1—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.75e-05	0.00111	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.73e-05	0.0011	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.73e-05	0.0011	CbGpPWpGaD
Oxprenolol—Dizziness—Lisinopril—dilated cardiomyopathy	1.73e-05	0.0127	CcSEcCtD
Oxprenolol—ADRB2—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.71e-05	0.00109	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.7e-05	0.00108	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.7e-05	0.00108	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.66e-05	0.00106	CbGpPWpGaD
Oxprenolol—Headache—Lisinopril—dilated cardiomyopathy	1.64e-05	0.0121	CcSEcCtD
Oxprenolol—ADRB2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.63e-05	0.00103	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.61e-05	0.00103	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.59e-05	0.00101	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.58e-05	0.00101	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.58e-05	0.001	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.55e-05	0.000989	CbGpPWpGaD
Oxprenolol—Nausea—Lisinopril—dilated cardiomyopathy	1.55e-05	0.0114	CcSEcCtD
Oxprenolol—ADRB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.53e-05	0.000972	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.33e-05	0.000849	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.3e-05	0.00083	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.26e-05	0.000805	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GPX1—dilated cardiomyopathy	1.22e-05	0.000775	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CD36—dilated cardiomyopathy	1.19e-05	0.000755	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.1e-05	0.000702	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.09e-05	0.000692	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.08e-05	0.000686	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—AGT—dilated cardiomyopathy	1.07e-05	0.00068	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.06e-05	0.000677	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	9.82e-06	0.000625	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—RAC1—dilated cardiomyopathy	9.6e-06	0.000611	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	9.38e-06	0.000597	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AGT—dilated cardiomyopathy	9.18e-06	0.000584	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.56e-06	0.000481	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.39e-06	0.000471	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	6.51e-06	0.000414	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—RAF1—dilated cardiomyopathy	6.37e-06	0.000405	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	6.27e-06	0.000399	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	6.1e-06	0.000389	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	5.5e-06	0.00035	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	4.46e-06	0.000284	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—EGFR—dilated cardiomyopathy	4.37e-06	0.000278	CbGpPWpGaD
